Filter
2680
Filtered Results: 2680
Text search:
infectious
substances
Featured
Recommendations
315
New Publications
644
Language
Document type
No document type
1513
Guidelines
459
Studies & Reports
302
Manuals
171
Strategic & Response Plan
84
Training Material
68
Fact sheets
44
Situation Updates
14
Brochures
10
Resource Platforms
7
Infographics
7
Dashboards/Maps
1
Countries / Regions
India
115
Kenya
96
South Africa
85
Global
71
Western and Central Europe
62
Nigeria
56
Ethiopia
45
Uganda
41
Tanzania
39
Zambia
39
Liberia
37
Ghana
36
Africa
36
Senegal
34
Latin America and the Carribbean
34
Sierra Leone
29
Namibia
29
Congo, Democratic Republic of
28
Myanmar / Burma
26
Nepal
25
Malawi
25
Ukraine
22
Rwanda
22
Eastern Europe
22
Russia
21
South–East Asia Region
19
Brazil
19
Syria
18
Indonesia
18
Burkina Faso
17
Philippines
16
Guinea
16
Mozambique
16
Cameroon
15
Bangladesh
15
Eswatini/ Swaziland
15
Lesotho
14
Haiti
13
Germany
13
Benin
12
Cambodia
12
West and Central Africa
12
Mali
12
Angola
12
Zimbabwe
11
Middle East and North Africa
10
Eastern Europe and Central Asia
10
East and Southern Africa
10
Côte d’Ivoire / Ivory Coast
10
Botswana
10
South Sudan
9
Asia
8
Guinea-Bissau
8
Western Pacific Region
8
Madagascar
8
Chad
7
Pakistan
7
Tajikistan
6
Georgia
6
Canada
5
Niger
5
Afghanistan
5
USA
5
Yemen
5
North Macedonia
4
Thailand
4
Togo
4
China
4
United Kingdom
4
Colombia
3
Gambia
3
Peru
3
Venezuela
3
Jordan
3
Paraguay
3
France
3
Portugal
3
Vietnam
3
Moldova
3
Central African Republic
3
Iraq
3
Switzerland
2
Iran
2
Albania
2
Fiji
2
Morocco
2
Japan
2
Belgium
2
Spain
2
Southern Africa
2
Argentina
2
Lebanon
2
Papua New Guinea
2
Sri Lanka
2
Sudan
2
Poland
2
Somalia
2
Timor Leste/ East Timor
1
Mexico
1
Serbia
1
Turkey
1
Singapore
1
Laos
1
Estonia
1
Kyrgyzstan
1
Congo-Brazzaville
1
Uzbekistan
1
Burundi
1
Malaysia
1
Austria
1
Bulgaria
1
Mauritania
1
Italy
1
Armenia
1
Hungary
1
Saudi Arabia
1
Luxembourg
1
Denmark
1
Maldives
1
Mauritius
1
Tunisia
1
Belarus
1
Latvia
1
Djibouti
1
Egypt
1
Romania
1
Greece
1
Palestine
1
Honduras
1
Bhutan
1
Authors & Publishers
Publication Years
Category
Countries
929
Clinical Guidelines
216
Public Health
133
Women & Child Health
133
Key Resources
123
Capacity Building
73
Pharmacy & Technologies
57
Annual Report MEDBOX
1
Toolboxes
Mental Health
279
HIV
265
COVID-19
241
TB
155
AMR
120
Rapid Response
99
Caregiver
95
Pharmacy
94
Ebola & Marburg
80
Planetary Health
74
NTDs
41
NCDs
40
Refugee
39
Disability
38
Conflict
36
Global Health Education
31
Specific Hazards
27
Zika
18
Natural Hazards
14
Health Financing Toolbox
11
Polio
11
Cholera
4
Social Ethics
3
Malaria
1
Nested case-control study of health workers exposed to confirmed COVID-19 patients.
Similar objectives to the cohort study but case-control studies may be cheaper and provide robust evidence to characterize and assess the risk factors for SARS-CoV-2 infection in health workers exposed to COVID-19 p...
This user guide is designed to provide national malaria control programmes with general information on glucose-6-phosphate dehydrogenase (G6PD) deficiency. Individuals with this condition may be at risk of adverse effects from medicines commonly used to cure Plasmodium vivax malaria, as well as from...
Prepared for the Stunting Prevention and Reduction Project - The project Medical Waste Management Plan’s (MWMP) overall objective is to prevent and/or mitigate the negative effects of increased generation of medical waste on human health and the environment. The plan proposes measures to prevent t...
Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy. This WHO operational handbook on tuberculosis. Module 6: tuberculosis and comorbidities aims to support countries in scaling up people-centred care, base...
Antimicrobial resistance (AMR) is a global threat that requires urgent collaborative action within and among countries. AMR makes standard treatments ineffective and facilitates the spread of antimicrobial resistant infections rendering communities vulnerable. The Ministry of Health (MOH) and Minist...
Guidelines for the Prevention and Contaiment of of Antimicrobial Resistance in South African Hospitals
recommended
These guidelines form part of efforts to institutionalize the prevention and containment of antimicrobial resistance (AMR) in healthcare facilities in South Africa, as outlined in the Antimicrobial Resistance Strategic Framework and Implementation Plan. The focus of these guidelines is on two interr...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons...
Pakistan Global Antibiotic Resistance Partnership (GARP) was formed in the wake of international and national efforts for AMR curtailment. A group of experts from microbiology, infectious diseases and veterinary medicine formed a core group at the organizational meet...
The issue of Antimicrobial resistance has become one of the most substantial health issues, prompting the World Health Assembly (WHA) to urge Member States to finalise tailor made national action plans by May 2017, aligning them with objectives of the Global Action Plan (GAP). These cover awareness,...
Antimicrobial resistance is a global threat as it is present in all parts of the world and it means that there is a shortage of effective antibiotics to treat simple infections and diseases, also statistics reveal that because of antimicrobial resistance patients’ morbidity and mortality is increa...
The report focuses on antibacterial resistance (ABR) in common bacterial pathogens. There is a major gap in knowledge about the magnitude of this problem. Antimicrobial resistance (AMR) threatens the effective revention and treatment of an ever-increasing range of infections caused by bacteria, para...
There is paucity of data on the burden and specific drivers operative in the pathogenesis of chronic obstructive pulmonary disease (COPD) in the African setting and populations. Lack of awareness and inadequate knowledge on the aetio-pathogenesis of the disease together with inadequate capacity for ...
Antimicrobials are medicines, including antibiotics, antivirals, antifungals, and antiparasitics, that are used to prevent and treat infections in humans, animals, and plants. Antimicrobial Resistance (AMR) arises when bacteria, viruses, fungi, and parasites no longer respond to these medicines, ren...
Guidelines for the Prevention and Containment of Antimicrobial Resistance in South African Hospitals
These guidelines form part of efforts to institutionalise the prevention and containment of antimicrobial resistance (AMR) in health care facilities in South Africa, as outlined in the Antimicrobial Resistance Strategic Framework and Implementation Plan. The focus of these guidelines is on two inte...
South Africa has faced many challenges over the past two decades, accomplishing profound positive changes in the social structure and government of the nation. This has not yet fully translated into better health for the population, however, particularly the poorest segment. In fact, the p...
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infect...
Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy. This WHO operational handbook on tuberculosis. Module 6: tuberculosis and comorbidities aims to support countries in scaling up people-centred care, ...
Antimicrobial resistance (AMR) is a global threat that requires urgent
collaborative action within and among countries. As a result of the worldwide reports of the increasing rates of AMR to hospital and community-acquired infections and in the agricultural sector, the Global Action Plan on AMR was...
Good Manufacturing Practice (GMP) describes a set of principles and procedures that, when followed, ensure that medicines and related substances are of high quality, safety and efficacy. SAHPRA is a
participating authority of the Pharmaceutical Inspection Cooperation Scheme (jointly known as PIC/S)...
Buruli ulcer (BU), a neglected tropical disease (NTD), is an infection of the skin and subcutaneous tissue caused by Mycobacterium ulcerans. The disease has been documented in many South American, Asian, and Western Pacific countries and is widespread throughout much of Africa, especially in West...
